http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Toyao, Takashi,Miyahara, Kenta,Fujiwaki, Mika,Kim, Tae-Ho,Dohshi, Satoru,Horiuchi, Yu,Matsuoka, Masaya American Chemical Society 2015 JOURNAL OF PHYSICAL CHEMISTRY C - Vol.119 No.15
<P>A catalytically competent Cu species has been immobilized within the framework of a Zr-based metal–organic framework with bipyridine units, Zr-MOF-bpy, by a simple postsynthetic modification method from CuBr<SUB>2</SUB> (Zr-MOF-bpy-CuBr<SUB>2</SUB>) and used for the selective oxidation of cyclooctene to cyclooctene oxide. Zr-MOF-bpy was synthesized by a simple solvothermal method and was shown to have a UiO-type structure. Diffuse reflectance UV–vis and XAFS measurements have revealed that the immobilized Cu species has a square-planar geometry of two N atoms and two Br atoms. Zr-MOF-bpy-CuBr<SUB>2</SUB> catalyzed the selective oxidation of cyclooctene to cyclooctene oxide with high activity and selectivity in the presence of <I>tert</I>-butyl hydroperoxide as an oxidant. In addition, the catalytic ability of Zr-MOF-bpy-CuBr<SUB>2</SUB> was demonstrated to be superior to that of the corresponding homogeneous catalyst ((bpy)CuBr<SUB>2</SUB>). It was also confirmed that Zr-MOF-bpy-CuBr<SUB>2</SUB> can be reused as a heterogeneous catalyst without significant loss of its activity and selectivity.</P><P><B>Graphic Abstract</B> <IMG SRC='http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jpccck/2015/jpccck.2015.119.issue-15/jp512749y/production/images/medium/jp-2014-12749y_0009.gif'></P><P><A href='http://pubs.acs.org/doi/suppl/10.1021/jp512749y'>ACS Electronic Supporting Info</A></P>
Matrices for the Analysis of Glycosphingolipids by LC-MS
Akemi Suzuki,Hideshi Fujiwaki,Yoshikatsu Umemura 한국당과학회 2012 한국당과학회 학술대회 Vol.2012 No.1
Recent advances in mass spectrometry make our view of glycosphingolipids (GSLs) com- pletely different from the previous one. LC-MS is applicable to GSL mixture in a smallamount, and provides structural information of carbohydrate chains and ceramides andpossibly quantitative results. However, several subjects remain to be carefully clarified.Critical subjects are matrices used for enhancing ionization of GSLs and the prepara- tion of standard or isotope-labeled GSLs for quantitation. We have tested several matrices for neutral GSLs and acidic GSLs (gangliosides) in the analysis of negative ion mode. Negative ion mode provides more fragment ions derived from carbohydrate chains and ceramides. Matrices used for LC analysis with a C30 reversed phase column of neutral GSLs, such as ammonium formate, formic acid, ammonium acetate, and acetic acid, give adduct ions and the ratios of molecularions [M - H]- and adduct ions are different among molecular species of GlcCer as the simplest neutral GSL. Ammonium bicarbonate containing solvents give lesser amount of adducts and can be used for comparing changes of molecular species of neutral GSLs produced by the different conditions of cultured cells or comparing neutral GSLs of different subsets of cells isolated from living organisms. In the analysis of gangliosides, we detected GM1(NeuAc) as a single charged ion [M – H]-,and GM1(NeuGc) as a double charged ion [M - 2H]-2. Other ganglisoides such as GD1, GT1, and GQ1 molecules were detected as double charged ions, therefore, GM1(NeuAc) gives the highest m/z values among these gangliosides, thus detection effi- ciency becomes very low. We have successfully applied LC-MS analysis to gangliosides of mouse thymocytes and CD4+ and CD8+ T cells (Nagafuku et al. 2012). Fortunately, these gangliosides contain N-glycolylneuraminic acid and give double charged ions, even in the case of GM1. When they are activated, the down regulation of CMP- NeuAc hydroxylase which is the rate liming step for the expression of NeuGc containing ganglisodies (Naito et al. 2007), is possibly triggered. Then, the sensitive detection of GM1(NeuAc) must be assured. This is also required for the analysis of microdomains of neuronal cell mem-brane of neural degenerative diseases such as Alzheimer disease and Parkinson disease.